## Abstract ## Objective Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established A
Cognitive decline and survival in Alzheimer's disease
β Scribed by Robert S. Wilson; Yan Li; Neelum T. Aggarwal; Judy J. McCann; David W. Gilley; Julia L. Bienias; Lisa L. Barnes; Denis A. Evans
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 92 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1472
No coin nor oath required. For personal study only.
β¦ Synopsis
Objective:
To test the association of rate of cognitive decline, an indicator of the severity of the underlying disease process, with risk of death in alzheimer's disease (ad).
Methods:
A total of 472 persons with clinically diagnosed ad were recruited from a memory disorders clinic and day care centers in the chicago area. they completed a uniform clinical evaluation at baseline and a battery of nine cognitive tests at six-month intervals for a mean of about three years. a previously established measure of global cognition was derived from the nine tests.
Results:
During follow-up, 168 persons (36%) died. in a proportional hazards model that controlled for age, sex, race, education, and baseline level of cognition, individual rate of global cognitive decline, estimated with least squares regression, was linearly related to mortality risk. thus, a person declining minimally (increase of 0.04 unit per year, 90th percentile) was 2.7 times less likely to die during the study period than a person declining rapidly (decrease of 0.76 unit per year, 10th percentile). controlling for baseline disability did not substantially affect results. the association of cognitive decline with mortality was substantially stronger for white persons compared to african americans and in those with less compared to more education.
Conclusion:
The results indicate that the rate at which cognition declines in ad is robustly related to survival.
π SIMILAR VOLUMES
## Abstract Data on the prevalence and severity of cognitive impairment among patients with newly diagnosed idiopathic Parkinson's disease (PD) is limited. Using a prospectively collected clinical database, we studied the longitudinal trend of miniβmental state examination (MMSE) change and baselin
## Abstract ## Objective To measure rates of decline in cognition and function in patients with Alzheimer's disease (AD) and to investigate their accelerating risk factors in Korea. ## Methods This study presents longitudinal data on a communityβbased sample of 107 patients with AD, followed at
Introduction. To trace the prodromal evolution of Alzheimer's disease using a comprehensive computerized cognitive battery and an evaluation of performance of everyday activities. Materials and methods. A general population cohort of 397 normal elderly persons hypothesized to have an increased risk
Although the hallmark of Alzheimer's disease (AD) is memory loss, behavioural and psychiatric disturbances are common and often pose the greatest problems for carers and patients. Modifying behavioural disturbance in AD sufferers can delay institutionalization and improve the quality of life of pati
## Abstract ## Objective To evaluate whether the relationship between extrapyramidal signs (EPS) and cognitive disturbances in Alzheimer's disease (AD) is influenced by illness duration. ## Methods A multivariate regression analysis was used to study the relationships between EPS, illness durati